EUVIMEDEUVIMED entdecken
Crossref

From Bench to Bedside: Eupatilin Activates Antioxidant Defenses and Reduces Fibrosis in Experimental Cholestasis

Wei-Lu Wang, Yan Chen, Paul Kwong Hang Tam

European Journal of Pediatric Surgery · 01.02.2026 · 36 (01) · 059-064

DOI: 10.1055/a-2676-2832 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pediatric Surgery, erschienen am 01.02.2026. Verfasst von Wei-Lu Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, School of Pharmacy, Macau University of Science and Technology, Macau SAR, China. Hauptthemen laut MEDLINE: Cholestasis, Antioxidants, Flavonoids, Liver Cirrhosis. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study is to explore the protective effects and mechanisms of Eupatilin, a peroxisome proliferator-activated receptor α (PPARα) agonist, on cholestatic liver disease induced by common bile duct ligation (BDL) in mice. We selected Balb/c mice (both male and female) aged 6 to 8 weeks for the common BDL procedure (ethical approval number: MUST-FDCT-20241114001). The groups include the BDL group and the BDL+ Eupatilin group, with three mice in each group. Once the mice developed jaundice postsurgery (5 days), they were treated with Eupatilin via gavage at a dosage of 20 mg/kg daily for a period of 8 days. On day 13, ocular blood was collected, and liver tissues were extracted for histopathological examination with H&E staining, Sirius Red staining, and subsequent RNA sequencing. Statistical differences among the parameters were evaluated using a t-test. Eupatilin reduces the liver weight/body weight ratio by 41% and ameliorates liver necrosis and fibrosis in Balb/c mice. It could decrease alanine transaminase ( p = 0.0498), aspartate aminotransferase (p = 0.0077), while maintaining ALB (Albumin) and γ-GT (gamma-glutamyl transferase) within normal ranges. RNA sequencing analysis revealed that antioxidant genes (acetaldehyde dehydrogenase 2 [Aldh2] and superoxide dismutase 1 [Sod1]) might be the targets of Eupatilin action. We found that Eupatilin can upregulate antioxidant genes (Aldh2; p = 0.0107) and Sod1 (p = 0.0208) of Balb/c mice, thereby ameliorating BDL damage in mice with cholestatic liver disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholestasisAntioxidantsFlavonoidsLiver CirrhosisAnimalsMice, Inbred BALB CMaleMiceFemaleLiverDisease Models, AnimalPPAR alpha

Substanzen

AntioxidantseupatilinFlavonoidsPPAR alpha

Autor:innen und Institutionen

  • Faculty of Medicine, School of Pharmacy, Macau University of Science and Technology, Macau SAR, China.
  • Precision Regenerative Medicine Research Centre, Medical Sciences Division, Macau University of Science and Technology, Macau SAR, China.

Zitieren

APA

Wang, W. L., Chen, Y., & Tam, P. K. H. (2026). From Bench to Bedside: Eupatilin Activates Antioxidant Defenses and Reduces Fibrosis in Experimental Cholestasis. European Journal of Pediatric Surgery, 36(01), 059-064. https://doi.org/10.1055/a-2676-2832

Vancouver

Wang WL, Chen Y, Tam PKH. From Bench to Bedside: Eupatilin Activates Antioxidant Defenses and Reduces Fibrosis in Experimental Cholestasis. European Journal of Pediatric Surgery. 2026;36(01):059-064. doi:10.1055/a-2676-2832

BibTeX
@article{Wang2026,
  author = {Wang, Wei-Lu and Chen, Yan and Tam, Paul Kwong Hang},
  title = {From Bench to Bedside: Eupatilin Activates Antioxidant Defenses and Reduces Fibrosis in Experimental Cholestasis},
  journal = {European Journal of Pediatric Surgery},
  year = {2026},
  volume = {36},
  number = {01},
  pages = {059--064},
  doi = {10.1055/a-2676-2832}
}
Kostenlos starten →